Mark Hanson

Mark Hanson currently serves as Senior Director of Enterprise Accounts at CluePoints, focusing on business development to enhance enterprise engagements with major clients such as AstraZeneca, GSK, Roche, and Novartis. Previously, Mark held senior business development roles at Science 37 and SAS, where responsibilities included managing key accounts and driving AI and analytics initiatives in the life sciences sector. Mark's extensive experience also includes leadership positions at Saama Technologies and Accelrys, where contributions to sales and strategic account management positively impacted revenue growth. With a solid academic foundation, including a Master's in Business Administration from Cardiff University and a B.Sc in Biochemistry from the University of Birmingham, Mark combines deep industry expertise with strategic market planning skills to drive business success.